<DOC>
	<DOCNO>NCT01327144</DOCNO>
	<brief_summary>Herpes Zoster infection affect part nervous system cause Varicella Zoster Virus . Herpes Zoster manifest vesicular eruption dermatome , often associate significant pain . There effective oral prescription antiviral medicine available reduce discomfort symptom famciclovir aciclovir . This phase III , multicenter , randomize , parallel-group study compare efficacy safety treatment Famciclovir ( 500 mg ) compare Aciclovir ( 400 mg ) patient Herpes Zoster .</brief_summary>
	<brief_title>Efficacy Oral Famciclovir Versus Aciclovir Treatment Patients With Herpes Zoster</brief_title>
	<detailed_description>Study Design - single blind study , prospective , parallel group , intent treat trial - Experiment duration : 7 day - 2 visit ( day 0 , 7 ) - Reduction symptom - Adverse event evaluation</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Famciclovir</mesh_term>
	<mesh_term>2-Aminopurine</mesh_term>
	<criteria>Patients must able understand study procedure , agree participate give write consent . Patients clinical diagnosis Herpes Zoster ; Score high 4 least 2 symptom Herpes Zoster ; Negative pregnant urine test Pregnancy risk pregnancy . Lactation Any pathology past medical condition interfere protocol . Nonsteroidal antiinflammatory drug , hormonal antiinflammatory immunosuppressive drug ( last 30 day study ) ; Patients immunodeficiency and/or immunosuppressive disease ; Hypersensitivity component formula ; Other condition deem reasonable medical investigator disqualification individual study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>